B-cell Malignancies Clinical Trials in Shenzhen, Guangdong
6 recruitingShenzhen, Guangdong, China
Showing 1–6 of 6 trials
Recruiting
Phase 1Phase 2
Combination CAR-T Cell Therapy Targeting Hematological Malignancies
B-cell Malignancies
Shenzhen Geno-Immune Medical Institute100 enrolled4 locationsNCT03125577
Recruiting
Phase 1Phase 2
A Phase I/II Multiple Center Trial of 4SCAR19 Cells in the Treatment of Relapsed and Refractory B Cell Malignancies
B-cell Malignancies
Shenzhen Geno-Immune Medical Institute200 enrolled2 locationsNCT03050190
Recruiting
Phase 1
4SCAR19U T Cells Targeting B Cell Malignancies
B-cell Malignancies
Shenzhen Geno-Immune Medical Institute30 enrolled1 locationNCT05995015
Recruiting
Phase 1Phase 2
CD19/70 Bi-specific CAR-T Cell Therapy
B-cell Malignancies
Shenzhen Geno-Immune Medical Institute30 enrolled1 locationNCT05436496
Recruiting
Phase 1Phase 2
CD19/79b Bi-specific CAR-T Cell Therapy
B-cell Malignancies
Shenzhen Geno-Immune Medical Institute60 enrolled1 locationNCT05436509
Recruiting
Phase 1Phase 2
CD19/22 Bi-specific CAR-T Cell Therapy
B-cell Malignancies
Shenzhen Geno-Immune Medical Institute60 enrolled1 locationNCT05432882